- Home
- DX vs BHVN Comparison
DX vs BHVN Comparison
Compare DX & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DX
- BHVN
- Stock Information
- Founded
- DX 1987
- BHVN 2013
- Country
- DX United States
- BHVN United States
- Employees
- DX N/A
- BHVN N/A
- Industry
- DX Real Estate Investment Trusts
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- DX Real Estate
- BHVN Health Care
- Exchange
- DX Nasdaq
- BHVN Nasdaq
- Market Cap
- DX 1.6B
- BHVN 1.5B
- IPO Year
- DX N/A
- BHVN 2017
- Fundamental
- Price
- DX $12.37
- BHVN $15.50
- Analyst Decision
- DX Buy
- BHVN Strong Buy
- Analyst Count
- DX 4
- BHVN 16
- Target Price
- DX $13.00
- BHVN $52.13
- AVG Volume (30 Days)
- DX 4.6M
- BHVN 2.2M
- Earning Date
- DX 10-20-2025
- BHVN 11-11-2025
- Dividend Yield
- DX 16.48%
- BHVN N/A
- EPS Growth
- DX 592.83
- BHVN N/A
- EPS
- DX 0.63
- BHVN N/A
- Revenue
- DX $107,764,000.00
- BHVN N/A
- Revenue This Year
- DX N/A
- BHVN N/A
- Revenue Next Year
- DX $70.80
- BHVN $2,195.07
- P/E Ratio
- DX $19.72
- BHVN N/A
- Revenue Growth
- DX 119.64
- BHVN N/A
- 52 Week Low
- DX $10.79
- BHVN $12.79
- 52 Week High
- DX $14.52
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- DX 42.68
- BHVN 55.86
- Support Level
- DX $12.32
- BHVN $13.41
- Resistance Level
- DX $12.59
- BHVN $14.23
- Average True Range (ATR)
- DX 0.19
- BHVN 0.87
- MACD
- DX -0.04
- BHVN -0.06
- Stochastic Oscillator
- DX 6.94
- BHVN 54.43
About DX Dynex Capital Inc.
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.